Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature (Q38095383)

28 August 2017

title

Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

1 reference

Mairead Skally

1

1 reference

28 August 2017

Paul Hanly

series ordinal

2

1 reference

28 August 2017

Linda Sharp

series ordinal

3

1 reference

28 August 2017

publication date

1 June 2013

1 reference

Applied Health Economics and Health Policy

28 August 2017

published in

1 reference

28 August 2017

volume

11

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

181-192

1 reference

Progress and challenges in colorectal cancer screening and surveillance

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Fecal DNA screening in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

The dynamics of colorectal cancer management in 17 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Contrasting US and European approaches to colorectal cancer screening: which is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Next-generation stool DNA testing: expanding the scope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Faecal screening of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Cost-effectiveness of colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Stool DNA and occult blood testing for screen detection of colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

The cost-effectiveness of screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Cost-effectiveness of colorectal cancer screening in the average risk population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Highly parallel genomic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Stool screening for colorectal cancer: molecular approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

The UK colorectal cancer screening pilot: results of the second round of screening in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Randomised study of screening for colorectal cancer with faecal-occult-blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Improved fecal DNA test for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

Sensitive digital quantification of DNA methylation in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-013-0010-8

10.1007/S40258-013-0010-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1026531965

0 references

Fatcat ID

release_24mkpmfrjvc2vjxroukuo4jhbq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/24mkpmfrjvc2vjxroukuo4jhbq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference